Skip to content

DR. N. VANDEPOELE

Active
Private limited companyfounded 2021active for 5 yearsOud Vliegveld 38, 8400 Oostende, BelgiumKBO/BCE: BE 0774.882.916
Summary

DR. N. VANDEPOELE has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12,319 and a net result of €241,819. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 11% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 01-10-2021 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.322.737.353 8400 Oostende, since 01-10-2021
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€313,694
▲ 38.5%
Turnover
≈ €480,000
estimated
Profit
€241,819
▲ 39.1%
Equity
€12,319
▼ 92.1%
Total assets
€212,528
▼ 17.7%
Score breakdownraises risk1 change of registered office in 24 monthsEquity €12,319 (5.8% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.95, cash €124,223Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 29% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 31-54
equity 5.8% of total assets
Liquidity 50-31
short-term debt 94.2% · cash 58.5%
Profitability 100=
return on assets 113.8%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.2 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.95 (2.51 in 2024), below 1. Short-term debt is 94.2% and cash 58.5% of total assets. 94.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 11% of them on solvency, 20% on liquidity, 80% on profitability and 5% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Liquidity: current ratio 0.95, cash €124,223
NBB · annual accounts
raises risk · Equity €12,319 (5.8% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 20706 sector peers (2025).
NBB · sector comparison
Position among 20706 sector peers
Solvency
better than 11%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-07-2026, 12 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
12 days early
2024
20 days late
2023
19 days late
2022
22 days late
2021
82 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 26 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 August (4 of the last 5 accounts filed within 32 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €155,351 to €12,319 ▼ 92.1% View
  • Caution: Lower solvency than 89% of companies in human healthsector median 63.0% · 20,706 companies 5.8% View
  • New directorlatest change 01-07-2026 · 2 in office 1 joined View
  • Positive: 5 profitable years in a rowprofit 2025: €241,819 5 years View

Recent changes

  1. · Gazette deed Appointment: Astrid Degimbe (director)
  2. · Gazette deed Registered office moved within OostendeNew seat: Oud Vliegveld 38 - 8400 Oostende · Previous seat: Frère-Orbanstraat 63 - 8400 Oostende
  3. · Gazette deed IncorporationAppointment: VANDEPOELE Nicolas Frans Odette (director)
All 12 events

Comparable companies

These companies have the same main activity as DR. N. VANDEPOELE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €207,000 and €241,000, founded between 2020 and 2021.

CompanyTotal assetsGross margin
DR. N. VANDEPOELE Oostende€212,528€313,694
DOCTEUR PIERRE LEPAGE Esneux€215,615€315,693
Dr. Van Nieuwenhove Saskia Erpe-Mere€217,206€305,180
TIOXIS Sint-Genesius-Rode€206,630€308,819
Dr. Valerie Van Goethem, Gynaecoloog Sint-Martens-Latem€240,726€316,427
CARDIORHYTHMICS Antwerpen€233,563€280,198
Dokter Astrid Lambrecht Sint-Gillis-Waas€239,219€293,265
Full comparison

Key facts about DR. N. VANDEPOELE

What is the company number of DR. N. VANDEPOELE?
The company number of DR. N. VANDEPOELE is 0774.882.916. The VAT number is the same number with BE in front: BE 0774.882.916.
Where is DR. N. VANDEPOELE based?
The registered office is at Oud Vliegveld 38, 8400 Oostende.Company details
What does DR. N. VANDEPOELE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. N. VANDEPOELE?
The legal form of DR. N. VANDEPOELE is Private limited company (BV).
When was DR. N. VANDEPOELE founded?
DR. N. VANDEPOELE was founded on 01-10-2021.
Is DR. N. VANDEPOELE still active?
Yes, DR. N. VANDEPOELE is an active enterprise in the KBO register.
What is the turnover of DR. N. VANDEPOELE?
The turnover in financial year 2025 is ≈ €480,000. This figure is estimated from the gross margin of €313,694 and 36 comparable companies (NACE 862). It probably lies between €430,000 and €610,000.Financials
Is DR. N. VANDEPOELE profitable?
In financial year 2025, DR. N. VANDEPOELE made a profit of €241,819.
Where can I find the annual accounts of DR. N. VANDEPOELE?
DR. N. VANDEPOELE filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. N. VANDEPOELE due?
DR. N. VANDEPOELE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.